Literature DB >> 29773917

Neurodegenerative disorders: Rescuing mitochondrial motility.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2018        PMID： 29773917     DOI： 10.1038/nrd.2018.76

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A.

Authors:  Agostinho G Rocha; Antonietta Franco; Andrzej M Krezel; Jeanne M Rumsey; Justin M Alberti; William C Knight; Nikolaos Biris; Emmanouil Zacharioudakis; James W Janetka; Robert H Baloh; Richard N Kitsis; Daria Mochly-Rosen; R Reid Townsend; Evripidis Gavathiotis; Gerald W Dorn
Journal:  Science       Date:  2018-04-20       Impact factor: 47.728
  1 in total
  2 in total

Review 1.  Mitofusin 2 Dysfunction and Disease in Mice and Men.

Authors:  Gerald W Dorn
Journal:  Front Physiol       Date:  2020-07-09       Impact factor: 4.566

2.  Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A.

Authors:  Antonietta Franco; Xiawei Dang; Emily K Walton; Joshua N Ho; Barbara Zablocka; Cindy Ly; Timothy M Miller; Robert H Baloh; Michael E Shy; Andrew S Yoo; Gerald W Dorn
Journal:  Elife       Date:  2020-10-19       Impact factor: 8.140
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.